Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Kollewe, Katja ^a   Wurster, Ulrich ^a   Sinzenich, Thomas ^a   Körner, Sonja ^a   Dengler, Reinhard ^a   Mohammadi, Bahram ^b,c   Petri, Susanne ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GA1 ANTIBODY; GANGLIOSIDE GD1A ANTIBODY; GANGLIOSIDE GD1B ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GM2 ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RILUZOLE; UNCLASSIFIED DRUG; GANGLIOSIDE;

ADULT; AGE; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE ASSESSMENT; PHENOTYPE; SEX DIFFERENCE; SURVIVAL RATE; VERY ELDERLY; DEMOGRAPHY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PHENOTYPE;

EID: 84929500875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125339     Document Type: Article

References (62)

1. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008 Dec 15; 275(1-2):69-73. doi: 10.1016/j.jns.2008.08.003 PMID: 18822434
2. Czaplinski A, Yen AA, Simpson EP, Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006 Dec; 34(6):702-8. PMID: 16967489
3. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006 Nov; 253(11):1428-36.
4. van Schaik IN, Bossuyt PM, Brand A, Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 1995 Aug; 45(8):1570-7. PMID: 7644057
5. Meuth SG, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. Eur Neurol 2010; 63(4):193-204. doi: 10.1159/000282734 PMID: 20150737
6. Vlam L, van der Pol WL, Cats EA, Straver DC, Piepers S, Franssen H, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol 2012 Jan; 8(1):48-58.
7. Taylor BV, Gross L, Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996 Oct; 47(4):951-5. PMID: 8857725
8. Cats EA, Jacobs BC, Yuki N, Tio-Gillen AP, Piepers S, Franssen H, et al. Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology 2010 Nov 30; 75(22):1961-7. doi: 10.1212/WNL.0b013e3181ff94c2 PMID: 20962291
9. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002 Dec; 125(Pt 12):2591-625. PMID: 12429589
10. Pestronk A, Adams RN, Clawson L, Cornblath D, Kuncl RW, Griffin D, et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 1988 Sep; 38(9):1457-61. PMID: 3412595
11. Lamb NL, Patten BM. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies. Muscle Nerve 1991 Oct; 14(10):1021-7. PMID: 1944401
12. Adams D, Kuntzer T, Burger D, Chofflon M, Magistris MR, Regli F, et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991 Jun; 32(3):223-30. PMID: 2033117
13. Kornberg AJ. Anti-GM1 ganglioside antibodies: their role in the diagnosis and pathogenesis of immune-mediated motor neuropathies. J Clin Neurosci 2000 May; 7(3):191-4. PMID: 10833614
14. Wolfgram F, Myers L. Amyotrophic lateral sclerosis: effect of serum on anterior horn cells in tissue culture. Science 1973 Feb 9; 179(4073):579-80. PMID: 4119685
15. Gurney ME, Belton AC, Cashman N, Antel JP. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med 1984 Oct 11; 311(15):933-9. PMID: 6472419
16. Yuki N, Yanaka C, Sudo M, Funakoshi M, Ishida H, Mori M, et al. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited. J Neuroimmunol 2014 Jul 15; 272(1-2):62-6. doi: 10.1016/j.jneuroim.2014.05.002 PMID: 24864013
17. Yu RK. Development regulation of ganglioside metabolism. Prog Brain Res 1994; 101:31-44. PMID: 8029460
18. Hamberger A, Svennerholm L. Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem 1971 Oct; 18(10):1821-9. PMID: 5118336
19. Ledeen RW, Wu G. GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium-calcium exchanger. Can J Physiol Pharmacol 2006 Mar; 84(3-4):393-402.
20. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 2007 May; 55(7):746-57. PMID: 17352383
21. Lloyd KO, Furukawa K. Biosynthesis and functions of gangliosides: recent advances. Glycoconj J 1998 Jul; 15(7):627-36. PMID: 9881769
22. Yu RK, Nakatani Y, Yanagisawa M. The role of glycosphingolipid metabolism in the developing brain. J Lipid Res 2009 Apr; 50 Suppl:S440-S445. doi: 10.1194/jlr.R800028-JLR200 PMID: 18845618
23. Ariga T. Pathogenic role of ganglioside metabolism in neurodegenerative diseases. J Neurosci Res 2014 Oct; 92(10):1227-42. doi: 10.1002/jnr.23411 PMID: 24903509
24. Furukawa K, Ohmi Y, Ohkawa Y, Tokuda N, Kondo Y, Tajima O, et al. Regulatory mechanisms of nervous systems with glycosphingolipids. Neurochem Res 2011 Sep; 36(9):1578-86. doi: 10.1007/s11064-011-0494-2 PMID: 21562747
25. Ogawa-Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 1992 Nov; 59(5):1844-9. PMID: 1402926
26. Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 1992 Oct; 32(4):487-93.
27. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993 Apr; 43(4):809-14.
28. Ogawa-Goto K, Funamoto N, Abe T, Nagashima K. Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem 1990 Nov; 55(5):1486-93.
29. Plomp JJ, Willison HJ. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 2009 Aug 15; 587(Pt 16):3979-99.
30. Willison HJ, O'Hanlon GM. The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol 1999 Dec; 100(1-2):3-12. PMID: 10695735
31. Liu JX, Willison HJ, Pedrosa-Domellof F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009 Jul; 50(7):3226-32. doi: 10.1167/iovs.08-3333 PMID: 19255160
32. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993 Oct; 43(10):1911-7. PMID: 8413947
33. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997 Jan 16; 745(1-2):32-6.
34. Chapman J, Sela BA, Wertman E, Michaelson DM. Antibodies to ganglioside GM1 in patients with Alzheimer's disease. Neurosci Lett 1988 Mar 31; 86(2):235-40. PMID: 3368123
35. Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagala A, et al. Anti-GM1 ganglioside antibodies in Parkinson's disease. Acta Neurol Scand 2002 Jul; 106(1):54-7. PMID: 12067330
36. Benkler M, Agmon-Levin N, Shoenfeld Y. Parkinson's disease, autoimmunity, and olfaction. Int J Neurosci 2009; 119(12):2133-43. doi: 10.3109/00207450903178786 PMID: 19916845
37. Marconi S, Acler M, Lovato L, De TL, Tedeschi E, Anghileri E, et al. Anti-GD2-like IgM autoreactivity in multiple sclerosis patients. Mult Scler 2006 Jun; 12(3):302-8. PMID: 16764343
38. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 1984 Apr; 132(4):1793-7.
39. Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993 Jan; 114(1):49-55. PMID: 8433097
40. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992 Jan; 107(1):111-21. PMID: 1578228
41. Ilyas AA, Mithen FA, Chen ZW, Cook SD. Anti-GM1 IgA antibodies in Guillain-Barre syndrome. J Neuroimmunol 1992 Jan; 36(1):69-76. PMID: 1735770
42. Nobile-Orazio E, Carpo M, Meucci N, Grassi MP, Capitani E, Sciacco M, et al. Guillain-Barre syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 1992 Jun; 109(2):200-6. PMID: 1634903
43. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008 Oct; 7(10):939-50. doi: 10.1016/S1474-4422(08)70215-1 PMID: 18848313
44. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996 Nov; 47(5):1317-20. PMID: 8909449
45. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 1994 Jan; 17(1):100-4. PMID: 8264687
46. Biessels GJ, Franssen H, van den Berg LH, Gibson A, Kappelle LJ, Venables GS, et al. Multifocal motor neuropathy. J Neurol 1997 Mar; 244(3):143-52. PMID: 9050954
47. Pestronk A, Adams RN, Cornblath D, Kuncl RW, Drachman DB, Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol 1989 Jan; 25(1):98-102. PMID: 2913936
48. Niebroj-Dobosz I, Jamrozik Z, Janik P, Hausmanowa-Petrusewicz I, Kwiecinski H. Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 1999 Oct; 100(4):238-43. PMID: 10694928
49. Niebroj-Dobosz I, Janik P, Kwiecinski H. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes. Eur J Neurol 2004 Jan; 11(1):13-6. PMID: 14692882
50. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000 Dec; 1(5):293-9. PMID: 11464847
51. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999 Oct 31; 169(1-2):13-21. PMID: 10540026
52. Eisele L, Durig J, Huttmann A, Duhrsen U, Assert R, Bokhof B, et al. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann Hematol 2012 Feb; 91(2):243-8. doi: 10.1007/s00277-011-1293-1 PMID: 21789623
53. Younes-Chennoufi AB, Leger JM, Hauw JJ, Preud'homme JL, Bouche P, Aucouturier P, et al. Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitope. Ann Neurol 1992 Jul; 32(1):18-23. PMID: 1379422
54. Ben Younes-Chennoufi A, Meininger V, Leger JM, Bouche P, Jauberteau MO, Baumann N. Antiganglioside antibodies in motor-neuron diseases and peripheral neuropathies: study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int 1992 Apr; 20(3):353-7. PMID: 1338972
55. Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990 Jul; 40(7):1067-72. PMID: 2162499
56. Latov N, Hays AP, Donofrio PD, Liao J, Ito H, McGinnis S, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 1988 May; 38(5):763-8. PMID: 2452383
57. Nobile-Orazio E, Carpo M, Legname G, Meucci N, Sonnino S, Scarlato G. Anti-GM1 IgM antibodies in motor neuron disease and neuropathy. Neurology 1990 Nov; 40(11):1747-50. PMID: 2234431
58. Khandelwal D, Bhatia M, Vivekanandan S, Singh S, Shukla G, Goyal V, et al. IgM anti-GM1 antibody titers in patients with monomelic amyotrophy. Neurol India 2006 Dec; 54(4):399-401. PMID: 17114851
59. Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol 1996 Apr; 39(4):539-43. PMID: 8619533
60. Farbu E, Rekand T, Tysnes OB, Aarli JA, Gilhus NE, Vedeler CA. GM1 antibodies in post-polio syndrome and previous paralytic polio. J Neuroimmunol 2003 Jun; 139(1-2):141-4. PMID: 12799033
61. Caudie C, Quittard PA, Bouhour F, Vial C, Garnier L, Fabien N. Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies. Clin Lab 2013; 59(11-12):1277-87.
62. Kusunoki S, Kaida K. Antibodies against ganglioside complexes in Guillain-Barre syndrome and related disorders. J Neurochem 2011 Mar; 116(5):828-32. doi: 10.1111/j.1471-4159.2010.07029.x PMID: 21214559